Prevalence of insulin resistance and metabolic syndrome in patients with gouty arthritis

Rheumatology International

Volumn 31, Issue 4, 2011, Pages 485-491

  Yoo, Han Gyul ^a   Lee, Sang Il ^b   Chae, Han Jung ^c   Park, Seoung Ju ^c   Lee, Yong Chul ^c   Yoo, Wan Hee ^c  

^a UNIVERSITY OF RHODE ISLAND   (United States)

^b Gyeongsang National University School of Medicine   (South Korea)

^c Chonbuk National University Medical School   (South Korea)

Author keywords

Gout; Insulin resistance; Metabolic syndrome

Indexed keywords

CHOLESTEROL; CREATININE; GLUCOSE; HIGH DENSITY LIPOPROTEIN; INSULIN; TRIACYLGLYCEROL; URIC ACID;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; BODY HEIGHT; BODY MASS; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CLINICAL ASSESSMENT; CONTROLLED STUDY; CORRELATIONAL STUDY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; GLUCOSE BLOOD LEVEL; GOUT; GROUPS BY AGE; HOMEOSTASIS; HUMAN; HYPERTENSION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; ONSET AGE; PRACTICE GUIDELINE; PRIORITY JOURNAL; SMOKING; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID URINE LEVEL; URINARY EXCRETION; WAIST CIRCUMFERENCE;

ADIPOSITY; ADULT; AGED; ARTHRITIS, GOUTY; CASE-CONTROL STUDIES; FEMALE; HUMANS; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PREVALENCE; URIC ACID;

EID: 79954450205     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00296-009-1304-x     Document Type: Article

References (35)

1. B Emmerson 1998 Hyperlipidaemia in hyperuricaemia and gout Ann Rheum Dis 57 9 509 510 9849306 10.1136/ard.57.9.509 1:STN:280:DyaK1M%2Fms1Wlug%3D%3D (Pubitemid 28474054)
2. AG Fam 2002 Gout, diet, and the insulin resistance syndrome J Rheumatol 29 7 1350 1355 12136887 1:CAS:528:DC%2BD38XmtVGjt7c%3D (Pubitemid 34755595)
3. Choi HK, Mount DB, Reginato AM; American College of Physicians; American Physiological Society (2005) Pathogenesis of gout. Ann Intern Med 143(7):499-516 (Pubitemid 41379398)
4. J Vázquez-Mellado CG García SG Vázquez G Medrano M Ornelas L Alcocer A Marquez R Burgos-Vargas 2004 Metabolic syndrome and ischemic heart disease in gout J Clin Rheumatol 10 3 105 109 17043480 10.1097/01.rhu.0000129082.42094.fc (Pubitemid 38821981)
5. YH Rho SJ Choi YH Lee JD Ji KM Choi SH Baik SH Chung CG Kim JY Choe SW Lee WT Chung GG Song 2005 The prevalence of metabolic syndrome in patients with gout: a multicenter study J Korean Med Sci 20 6 1029 1033 16361817 10.3346/jkms.2005.20.6.1029 1:CAS:528:DC%2BD28XhtVKgtbw%3D
6. WY Lee JS Park SY Noh EJ Rhee SW Kim PZ Zimmet 2004 Prevalence of the metabolic syndrome among 40,698 Korean metropolitan subjects Diabetes Res Clin Pract 65 2 143 149 15223226 10.1016/j.diabres.2003.12.007 (Pubitemid 38829683)
7. YH Rho SJ Choi YH Lee JD Ji KM Choi SH Baik GG Song 2004 Prevalence of the metabolic syndrome in patients with gout J Korean Rheum Assoc 11 4 349 357
8. M Trevisan J Liu FB Bahsas A Menotti 1998 Syndrome X and mortality: a population-based study. Risk Factor and Life Expectancy Research Group Am J Epidemiol 148 10 958 966 9829867 1:STN:280:DyaK1M%2FksFegsA%3D%3D
9. ES Ford 2005 Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence Diabetes Care 28 7 1769 1778 15983333 10.2337/diacare.28.7.1769 (Pubitemid 40923091)
10. J Lee D Sparrow PS Vokonas L Landsberg ST Weiss 1995 Uric acid and coronary heart disease risk: evidence for a role of uric acid in the obesity-insulin resistance syndrome. The Normative Aging Study Am J Epidemiol 142 3 288 294 7631632 1:STN:280:DyaK2MzlvVWntQ%3D%3D
11. W Rathmann E Funkhouser AR Dyer JM Roseman 1998 Relations of hyperuricemia with the various components of the insulin resistance syndrome in young black and white adults: the CARDIA study. Coronary artery risk development in young adults Ann Epidemiol 8 4 250 261 9590604 10.1016/S1047-2797(97)00204-4 1:STN:280:DyaK1c3ltVCrtA%3D%3D (Pubitemid 28208943)
12. F Facchini YD Chen CB Hollenbeck GM Reaven 1991 Relationship between resistance to insulin-mediated glucose uptake, urinary uric acid clearance, and plasma uric acid concentration JAMA 266 21 3008 3011 1820474 10.1001/jama.266.21.3008 1:CAS:528:DyaK38Xls1yrtLg%3D
13. SL Wallace H Robinson AT Masi JL Decker DJ McCarty TF Yü 1977 Preliminary criteria for the classification of the acute arthritis of primary gout Arthritis Rheum 20 3 895 900 856219 10.1002/art.1780200320 1:STN:280:DyaE2s7otFKitg%3D%3D
14. DR Matthews JP Hosker AS Rudenski BA Naylor DF Treacher RC Turner 1985 Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man Diabetologia 28 7 412 419 3899825 10.1007/BF00280883 1:CAS:528:DyaL2MXlslKnu7k%3D (Pubitemid 15018832)
15. SH Park WY Lee SW Kim 2003 The relative risks of the metabolic syndrome defined by adult treatment panel 3 according to insulin resistance in Korean population Korean J Med 64 5 552 561
16. National Institutes of Health (2001) Third report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). NIH Publication 01-3670. National Institutes of Health, Bethesda
17. Steering Committee of the WHO Western Pacific Region, IASO & IOTF (2000) The Asia-Pacific perspective: Redefining obesity and its treatment. Steering Committee of the WHO Western Pacific Region, IASO & IOTF, Australia
18. JS Park HD Park JW Yun CH Jung WY Lee SW Kim 2002 Prevalence of the metabolic syndrome as defined by NCEP-ATPIII among the urban Korean population Korean J Med 63 3 290 299
19. HE Lebovitz 2001 Insulin resistance: definition and consequences Exp Clin Endocrinol Diabetes 109 S135 S148 11460565 10.1055/s-2001-18576 1:CAS:528:DC%2BD3MXlslKgtbk%3D (Pubitemid 32577577)
20. C Bogardus S Lillioja DM Mott C Hollenbeck G Reaven 1985 Relationship between degree of obesity and in vivo insulin action in man Am J Physiol 248 E286 E291 3883799 1:CAS:528:DyaL2MXhsVOjtLc%3D
21. KC Lin HY Lin P Chou 2000 Community based epidemiological study on hyperuricemia and gout in Kin-Hu, Kinmen J Rheumatol 27 4 1045 1050 10782835 1:STN:280:DC%2BD3c3kt12huw%3D%3D (Pubitemid 30389766)
22. EH Kim KM Jeon KW Park HJ Kim JK Ahn CH Jeon HS Cha EM Koh 2004 The prevalence of gout among hyperuricemic population J Korean Rheum Assoc 11 1 7 13
23. H Vuorinen-Markkola H Yki-Järvinen 1994 Hyperuricemia and insulin resistance J Clin Endocrinol Metab 78 1 25 29 8288709 10.1210/jc.78.1.25 1:STN:280:DyaK2c7hslKhsw%3D%3D (Pubitemid 24026741)
24. JO Clausen K Borch-Johnsen H Ibsen O Pedersen 1998 Analysis of the relationship between fasting serum uric acid and the insulin sensitivity index in a population-based sample of 380 young healthy Caucasians Eur J Endocrinol 138 1 63 69 9461318 10.1530/eje.0.1380063 1:CAS:528:DyaK1cXhtVCjs7o%3D (Pubitemid 28078811)
25. B Rocić M Vucić-Lovrencić N Poje F Bertuzzi 2005 Uric acid may inhibit glucose-induced insulin secretion via binding to an essential arginine residue in rat pancreatic beta-cells Bioorg Med Chem Lett 15 4 1181 1184 15686937 10.1016/j.bmcl.2004.12.003 (Pubitemid 40458669)
26. H Hara G Egusa M Yamakido 1996 Incidence of non-insulin-dependent diabetes mellitus and its risk factors in Japanese-Americans living in Hawaii and Los Angeles Diabet Med 13 6 S133 S142 8894497 1:STN:280: DyaK2s%2FkvFOluw%3D%3D
27. KC Lin ST Tsai HY Lin P Chou 2004 Different progressions of hyperglycemia and diabetes among hyperuricemic men and women in the kinmen study J Rheumatol 31 6 1159 1165 15170930 (Pubitemid 38715893)
28. P Chou CL Li GS Wu ST Tsai 1998 Progression to type 2 diabetes among high-risk groups in Kin-Chen, Kinmen. Exploring the natural history of type 2 diabetes Diabetes Care 21 7 1183 1187 9653617 10.2337/diacare.21.7.1183 1:STN:280:DyaK1czhslCquw%3D%3D (Pubitemid 28368530)
29. Nakanishi N, Okamoto M, Yoshida H, Matsuo Y, Suzuki K, Tatara K (2003) Serum uric acid and risk for development of hypertension and impaired fasting glucose or Type II diabetes in Japanese male office workers. Eur J Epidemiol 18(6):523-530 (Pubitemid 36899556)
30. Y Taniguchi T Hayashi K Tsumura G Endo S Fujii K Okada Y Taniguchi T Hayashi K Tsumura G Endo S Fujii K Okada 2001 Serum uric acid and the risk for hypertension and Type 2 diabetes in Japanese men: The Osaka Health Survey J Hypertens 19 7 1209 1215 11446710 10.1097/00004872-200107000-00005 1:CAS:528:DC%2BD3MXltVGktr8%3D (Pubitemid 32595276)
31. SJ Bakker RO Gans JC ter Maaten T Teerlink HV Westerhoff RJ Heine 2001 The potential role of adenosine in the pathophysiology of the insulin resistance syndrome Atherosclerosis 155 2 283 290 11254897 10.1016/S0021-9150(00)00745-0 1:CAS:528:DC%2BD3MXhvVanu78%3D (Pubitemid 32209297)
32. R Roubenoff MJ Klag LA Mead KY Liang AJ Seidler MC Hochberg 1991 Incidence and risk factors for gout in white men JAMA 266 21 3004 3007 1820473 10.1001/jama.266.21.3004 1:STN:280:DyaK38zhvVersg%3D%3D
33. PH Dessein EA Shipton AE Stanwix BI Joffe J Ramokgadi 2000 Beneficial effects of weight loss associated with moderate calorie/carbohydrate restriction, and increased proportional intake of protein and unsaturated fat on serum urate and lipoprotein levels in gout: a pilot study Ann Rheum Dis 59 7 539 543 10873964 10.1136/ard.59.7.539 1:CAS:528:DC%2BD3cXlsF2hs70%3D (Pubitemid 30445833)
34. G Boden 1996 Fatty acids and insulin resistance Diabetes Care 19 4 394 395 8729171 10.2337/diacare.19.4.394 1:STN:280:DyaK28zltFCnsQ%3D%3D (Pubitemid 26115469)
35. G Boden 1997 Role of fatty acids in the pathogenesis of insulin resistance and NIDDM Diabetes 46 1 3 10 8971073 10.2337/diabetes.46.1.3 1:CAS:528:DyaK2sXks1aj (Pubitemid 27009941)